Sara K Tedeschi1, Jing Cui2, Elizabeth V Arkema3, William H Robinson4, Jeremy Sokolove4, Nithya Lingampalli4, Jeffrey A Sparks2, Elizabeth W Karlson2, Karen H Costenbader2. 1. Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, 75 Francis St, Boston, MA 02115. Electronic address: stedeschi1@partners.org. 2. Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, 75 Francis St, Boston, MA 02115. 3. Department of Medicine, Karolinska Institutet, Solna, Stockholm, Sweden. 4. Division of Immunology and Rheumatology, Stanford University, Palo Alto, CA.
Abstract
OBJECTIVE: Overweight/obesity and anti-citrullinated protein antibodies (ACPA) increase rheumatoid arthritis (RA) risk. We investigated the relationship between body mass index (BMI) and ACPA, tested for an interaction between BMI and ACPA for RA risk, and examined effects of BMI and ACPA on time to RA diagnosis. DESIGN: Within the Nurses' Health Studies, blood samples were collected before diagnosis from medical record-confirmed incident RA cases and matched controls. Multiplex assays measured 7 ACPA subtypes (biglycan, clusterin, enolase, fibrinogen, histone 2A, histone 2B, and vimentin). Logistic regression analyses tested the association of BMI and ACPA and for a multiplicative interaction between BMI groups (≥25 vs. <25kg/m2) and ACPA positivity (≥2 vs. <2 subtypes), adjusting for age, smoking, alcohol use, and HLA-shared epitope. In case-only analyses, log-rank tests compared time from blood draw to RA onset by cross-classified BMI/ACPA status. RESULTS: Among 255 pre-RA cases and 778 matched controls, 15.7% vs. 2.1% (p<0.001) had ≥2 ACPA and 49.4% vs. 40.2% (p<0.01) were overweight/obese. Continuous BMI was not associated with presence of ≥2 ACPA [OR per kg/m2 unit BMI: 1.03 (95% CI: 0.97-1.09)]. However, there was a multiplicative interaction between elevated BMI and the presence of ≥2 ACPA for RA risk (p = 0.027). Women with BMI≥25kg/m2 and ≥2 ACPA had OR 22.7 (95% CI: 6.64-77.72) for RA. Median time to RA differed by BMI/ACPA group (overall log-rank p<0.001) and was shortest among women with ≥2 ACPA and BMI≥25kg/m2 [45.0 months, IQR: 17.5-72.5] and longest in women with <2 ACPA and BMI<25kg/m2 [125.0 months, IQR: 72.0-161.0] (pairwise log-rank p = 0.002). CONCLUSION: Elevated BMI and presence of ACPA interacted to increase RA risk. Time to RA onset was shortest among overweight/obese women with ≥2 ACPA.
OBJECTIVE: Overweight/obesity and anti-citrullinated protein antibodies (ACPA) increase rheumatoid arthritis (RA) risk. We investigated the relationship between body mass index (BMI) and ACPA, tested for an interaction between BMI and ACPA for RA risk, and examined effects of BMI and ACPA on time to RA diagnosis. DESIGN: Within the Nurses' Health Studies, blood samples were collected before diagnosis from medical record-confirmed incident RA cases and matched controls. Multiplex assays measured 7 ACPA subtypes (biglycan, clusterin, enolase, fibrinogen, histone 2A, histone 2B, and vimentin). Logistic regression analyses tested the association of BMI and ACPA and for a multiplicative interaction between BMI groups (≥25 vs. <25kg/m2) and ACPA positivity (≥2 vs. <2 subtypes), adjusting for age, smoking, alcohol use, and HLA-shared epitope. In case-only analyses, log-rank tests compared time from blood draw to RA onset by cross-classified BMI/ACPA status. RESULTS: Among 255 pre-RA cases and 778 matched controls, 15.7% vs. 2.1% (p<0.001) had ≥2 ACPA and 49.4% vs. 40.2% (p<0.01) were overweight/obese. Continuous BMI was not associated with presence of ≥2 ACPA [OR per kg/m2 unit BMI: 1.03 (95% CI: 0.97-1.09)]. However, there was a multiplicative interaction between elevated BMI and the presence of ≥2 ACPA for RA risk (p = 0.027). Women with BMI≥25kg/m2 and ≥2 ACPA had OR 22.7 (95% CI: 6.64-77.72) for RA. Median time to RA differed by BMI/ACPA group (overall log-rank p<0.001) and was shortest among women with ≥2 ACPA and BMI≥25kg/m2 [45.0 months, IQR: 17.5-72.5] and longest in women with <2 ACPA and BMI<25kg/m2 [125.0 months, IQR: 72.0-161.0] (pairwise log-rank p = 0.002). CONCLUSION: Elevated BMI and presence of ACPA interacted to increase RA risk. Time to RA onset was shortest among overweight/obesewomen with ≥2 ACPA.
Authors: Aase Haj Hensvold; Thomas Frisell; Patrik K E Magnusson; Rikard Holmdahl; Johan Askling; Anca Irinel Catrina Journal: Ann Rheum Dis Date: 2016-04-28 Impact factor: 19.103
Authors: Catriona A Wagner; Jeremy Sokolove; Lauren J Lahey; Camilla Bengtsson; Saedis Saevarsdottir; Lars Alfredsson; Michelle Delanoy; Tamsin M Lindstrom; Roger P Walker; Reuven Bromberg; Piyanka E Chandra; Steven R Binder; Lars Klareskog; William H Robinson Journal: Ann Rheum Dis Date: 2013-12-02 Impact factor: 19.103
Authors: Y Zhang; M Peltonen; J C Andersson-Assarsson; P-A Svensson; C Herder; A Rudin; Lms Carlsson; C Maglio Journal: Scand J Rheumatol Date: 2020-07-15 Impact factor: 3.641
Authors: Su H Chu; Jing Cui; Jeffrey A Sparks; Bing Lu; Sara K Tedeschi; Cameron B Speyer; LauraKay Moss; Marie L Feser; Lindsay B Kelmenson; Elizabeth A Mewshaw; Jess D Edison; Kevin D Deane; Clary Clish; Jessica Lasky-Su; Elizabeth W Karlson; Karen H Costenbader Journal: Rheumatology (Oxford) Date: 2020-11-01 Impact factor: 7.580
Authors: Sara K Tedeschi; Medha Barbhaiya; Susan Malspeis; Bing Lu; Jeffrey A Sparks; Elizabeth W Karlson; Walter Willett; Karen H Costenbader Journal: Semin Arthritis Rheum Date: 2017-05-25 Impact factor: 5.532
Authors: Alessandra Zaccardelli; Xinyi Liu; Julia A Ford; Jing Cui; Bing Lu; Su H Chu; Peter H Schur; Cameron B Speyer; Karen H Costenbader; William H Robinson; Jeremy Sokolove; Elizabeth W Karlson; Carlos A Camargo; Jeffrey A Sparks Journal: Arthritis Care Res (Hoboken) Date: 2021-04 Impact factor: 4.794
Authors: Gregg E Dinse; Christine G Parks; Clarice R Weinberg; Caroll A Co; Jesse Wilkerson; Darryl C Zeldin; Edward K L Chan; Frederick W Miller Journal: Arthritis Rheumatol Date: 2020-04-30 Impact factor: 15.483
Authors: Alessandra Zaccardelli; Xinyi Liu; Julia A Ford; Jing Cui; Bing Lu; Su H Chu; Peter H Schur; Cameron B Speyer; Karen H Costenbader; William H Robinson; Jeremy Sokolove; Elizabeth W Karlson; Carlos A Camargo; Jeffrey A Sparks Journal: Arthritis Res Ther Date: 2019-11-21 Impact factor: 5.156